Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYRN

Cyren (CYRN) Stock Price, News & Analysis

Cyren logo

About Cyren Stock (NASDAQ:CYRN)

Key Stats

Today's Range
N/A
50-Day Range
$0.21
$0.92
52-Week Range
N/A
Volume
1.15 million shs
Average Volume
1.43 million shs
Market Capitalization
$1.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyren and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CYRN Stock News Headlines

Peyto Exploration&Development Corp (PEY)
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
Why Is Cyren (CYRN) Stock Down 27% Today?
Cyren Announces Nasdaq Delisting Determination
Cyren Announces Liquidation
Why Is Cyren (CYRN) Stock Up 43% Today?
See More Headlines

CYRN Stock Analysis - Frequently Asked Questions

Cyren Ltd. (NASDAQ:CYRN) posted its quarterly earnings data on Monday, November, 15th. The technology company reported ($0.06) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.06). The technology company had revenue of $7.46 million for the quarter. Cyren had a negative trailing twelve-month return on equity of 206.16% and a negative net margin of 123.96%.

The following companies are subsidiaries of Cyren: eleven GmbH, FRISK Software International, Authentium, Wingtra, Cyren Gesellschaft mbH, Cyren Iceland hf, Cyren Inc., and Cyren UK Ltd..

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyren investors own include Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Vaxart (VXRT), Acasti Pharma (ACST), iBio (IBIO), Oragenics (OGEN) and OpGen (OPGN).

Company Calendar

Last Earnings
11/15/2021
Today
9/19/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRN
CIK
1084577
Employees
200
Year Founded
1991

Profitability

EPS (Trailing Twelve Months)
($5.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.04 million
Net Margins
-123.96%
Pretax Margin
-94.37%
Return on Equity
-206.16%
Return on Assets
-48.72%

Debt

Debt-to-Equity Ratio
2.30
Current Ratio
1.29
Quick Ratio
1.29

Sales & Book Value

Annual Sales
$31.19 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.05 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,780,000
Free Float
7,539,000
Market Cap
$1.70 million
Optionable
Not Optionable
Beta
0.83

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CYRN) was last updated on 9/20/2025 by MarketBeat.com Staff
From Our Partners